4.88
price up icon2.31%   0.11
after-market 시간 외 거래: 4.97 0.09 +1.84%
loading
전일 마감가:
$4.77
열려 있는:
$4.76
하루 거래량:
157.33K
Relative Volume:
0.82
시가총액:
$221.04M
수익:
$84.82M
순이익/손실:
$-21.43M
주가수익비율:
-9.9592
EPS:
-0.49
순현금흐름:
$-27.23M
1주 성능:
+12.70%
1개월 성능:
+3.83%
6개월 성능:
-19.87%
1년 성능:
-61.05%
1일 변동 폭
Value
$4.70
$4.96
1주일 범위
Value
$4.29
$5.005
52주 변동 폭
Value
$3.55
$16.11

Y Mabs Therapeutics Inc Stock (YMAB) Company Profile

Name
명칭
Y Mabs Therapeutics Inc
Name
전화
646-885-8505
Name
주소
202 CARNEGIE CENTER, PRINCETON, NY
Name
직원
107
Name
트위터
Name
다음 수익 날짜
2025-03-04
Name
최신 SEC 제출 서류
Name
YMAB's Discussions on Twitter

YMAB을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
YMAB
Y Mabs Therapeutics Inc
4.88 216.06M 84.82M -21.43M -27.23M -0.49
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.83 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.63 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.79 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
595.19 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.54B 3.81B -644.79M -669.77M -6.24

Y Mabs Therapeutics Inc Stock (YMAB) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-22 다운그레이드 BofA Securities Neutral → Underperform
2024-11-18 개시 Oppenheimer Outperform
2024-08-16 개시 Cantor Fitzgerald Overweight
2024-06-28 개시 Truist Buy
2023-05-10 업그레이드 Wedbush Neutral → Outperform
2023-04-03 다운그레이드 Guggenheim Buy → Neutral
2023-01-27 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2023-01-05 다운그레이드 Cowen Outperform → Market Perform
2022-12-02 다운그레이드 BofA Securities Buy → Neutral
2022-10-31 다운그레이드 JP Morgan Neutral → Underweight
2022-10-31 다운그레이드 Wedbush Outperform → Neutral
2022-07-06 재개 Canaccord Genuity Buy
2022-06-24 개시 BMO Capital Markets Outperform
2022-02-03 재개 Guggenheim Buy
2021-11-19 재개 Morgan Stanley Equal-Weight
2021-11-16 다운그레이드 JP Morgan Overweight → Neutral
2021-05-07 업그레이드 BofA Securities Neutral → Buy
2021-04-23 재개 Cowen Outperform
2021-03-22 재개 JP Morgan Overweight
2021-01-15 다운그레이드 BofA Securities Buy → Neutral
2020-11-09 재확인 H.C. Wainwright Buy
2020-05-05 개시 Barclays Overweight
2020-05-01 개시 Janney Buy
2020-04-29 개시 Morgan Stanley Equal-Weight
2019-12-24 개시 JP Morgan Overweight
2019-11-20 개시 Guggenheim Buy
2019-09-04 개시 Wedbush Outperform
2019-04-01 개시 H.C. Wainwright Buy
2018-10-16 개시 BTIG Research Buy
2018-10-16 개시 BofA/Merrill Buy
모두보기

Y Mabs Therapeutics Inc 주식(YMAB)의 최신 뉴스

pulisher
06:50 AM

Does Y mAbs Therapeutics Inc. stock perform well during market downturnsMarket-leading growth rates - jammulinksnews.com

06:50 AM
pulisher
06:42 AM

How does Y mAbs Therapeutics Inc. compare to its industry peersMaximize your portfolio’s growth potential - jammulinksnews.com

06:42 AM
pulisher
05:57 AM

Combining price and volume data for Y mAbs Therapeutics Inc.Daily Market Momentum and Pressure Analysis - Newser

05:57 AM
pulisher
Jul 27, 2025

What are Y mAbs Therapeutics Inc. company’s key revenue driversGet ahead with breakthrough trading ideas - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Should I hold or sell Y mAbs Therapeutics Inc. stock in 2025Free High-Return Strategy Alerts - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

New Product Launches: Will They Boost Y mAbs Therapeutics Inc. Stock in 2025Free Expert Investment Advice - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

What is Y mAbs Therapeutics Inc. company’s growth strategyConsistent high-yield stocks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What catalysts could drive Y mAbs Therapeutics Inc. stock higher in 2025Get professional advice for portfolio optimization - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How strong is Y mAbs Therapeutics Inc. company’s balance sheetMaximize your portfolio’s earning potential - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

What drives Y mAbs Therapeutics Inc. stock priceFree Stock Market Beginners Guide - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

YmAbs Therapeutics (YMAB) Upgraded to Buy: Here's What You Should Know - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

Will Y mAbs Therapeutics Inc. stock split in the near futureOutperformance with explosive growth - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Y mAbs Therapeutics Inc. stockFree Predictions - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Will Y mAbs Therapeutics Inc. stock benefit from AI tech trendsHigh-profit capital plays - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Should I buy Y mAbs Therapeutics Inc. stock before earningsFree Predictions - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Following a 61% decline over last year, recent gains may please Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) institutional owners - simplywall.st

Jul 24, 2025
pulisher
Jul 23, 2025

How the (YMAB) price action is used to our Advantage - news.stocktradersdaily.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Y mAbs Therapeutics Inc. a good long term investmentMarket-beating performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Y mAbs Therapeutics Inc. Stock Analysis and ForecastUnrivaled growth potential - Autocar Professional

Jul 21, 2025
pulisher
Jul 16, 2025

Y-Mabs Therapeutics Elects New Director at Annual Meeting - The Globe and Mail

Jul 16, 2025
pulisher
Jul 15, 2025

Y-mAbs Therapeutics announces results of annual shareholder meeting votes - Investing.com

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Y mAbs Therapeutics Inc. stock price move sharplySafe and Smart Investment Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Y mAbs Therapeutics Inc. stock attracts strong analyst attentionFree Risk Assessment Services - Newser

Jul 15, 2025

Y Mabs Therapeutics Inc (YMAB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Y Mabs Therapeutics Inc 주식 (YMAB) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Rossi Michael J
PRESIDENT & CEO
Mar 07 '25
Sale
5.20
3,917
20,368
137,083
Gad Thomas
CHIEF BUSINESS OFFICER
Mar 07 '25
Sale
5.23
10,810
56,536
202,721
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
자본화:     |  볼륨(24시간):